Revolutionising Multiple Myeloma Treatment: The Daratumumab Injection Market
Multiple myeloma is a complex haematological malignancy that remains challenging to treat, but the introduction of targeted therapies has transformed patient outcomes. Daratumumab, a monoclonal antibody targeting CD38, has emerged as a cornerstone of multiple myeloma treatment, demonstrating significant efficacy both as monotherapy and in combination regimens. Available in intravenous and...
0 Yorumlar 0 hisse senetleri 0 önizleme